ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Otolaryngology 2014, Vol 4(4): 173
  • DOI: 10.4172/2161-119X-1000173

Dymista© Nasal Spray with Multifocal Analysis of its Impact on the Rhinitis Disease Experience

Amtul Salam Sami1* and Nida Ahmed2
1ENT and Allergy Department, Royal National Throat, Nose and Ear Hospital, University College London Hospitals, , London, UK
2King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, , London, UK
*Corresponding Author : Dr. Amtul Salam Sami, 1 Cow Leaze, E6 6WX, ENT and Allergy Department, Nose and Ear Hospital, University College London Hospitals, London, UK, Tel: 020 7474 2595, Email: amtul_salam@hotmail.com

Received Date: Aug 08, 2014 / Accepted Date: Sep 19, 2014 / Published Date: Sep 25, 2014

Abstract

Background: Rhinitis is a prevalent condition both in primary care and in specialist centres. It has been shown to significantly impact on quality of life. Treatment is often best managed on combined therapies. Dymista© nasal spray is filling a niche for an ‘all in one’ treatment of allergic rhinitis. Method: The MSNOT-20 is a valid disease specific quality of life instrument for rhinitis and rhinosinusitis and it was used to evaluate the symptomatic response to treatment with Dymista nasal spray. Results: Dymista has been shown to improve all domains of the patient experience of rhinitis and rhinosinusitis with positive feedback by both patients and prescribing physicians. Conclusion: Dymista is effective at improving patient symptomatology and improves quality of life. These positive results have opened up further avenues for research to explore its efficiency and place as mode of treatment.

Citation: Sami AS, Ahmed N (2014) Dymista© Nasal Spray with Multifocal Analysis of its Impact on the Rhinitis Disease Experience. Otolaryngol (Sunnyvale) 4:173. Doi: 10.4172/2161-119X-1000173

Copyright: © 2014 Hutton J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top